2020 ASCO Virtual Direct™ Highlights


 

Targeting Exon 20 Insertions in NSCLC: Anti-Tumor Activity With T-Dxd in HER2m Disease, Assessing Efficacy of Treatment Options in EGFRm Disease

327 views
January 28, 2021
Comments 0
Login to view comments. Click here to Login